Introduction
Hematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. They include
leukemias, lymphomas, and multiple myelomas. These malignancies are characterized by the uncontrolled proliferation of abnormal blood cells. Histology, the study of tissues at the microscopic level, plays a crucial role in diagnosing and understanding these diseases.
Leukemia: This involves cancerous proliferation of white blood cells (WBCs) in the bone marrow.
Lymphoma: This affects the lymphatic system, primarily the lymph nodes.
Multiple Myeloma: This involves abnormal plasma cells accumulating in the bone marrow.
Bone marrow biopsy: This involves extracting a small sample of bone marrow tissue, which is then stained and examined for abnormal cells.
Immunohistochemistry (IHC): This technique uses antibodies to detect specific antigens in cells, helping to identify the type of malignancy.
Flow cytometry: This analyzes the physical and chemical characteristics of cells or particles, aiding in the identification and classification of hematologic malignancies.
What are the Histological Features of Leukemia?
Leukemia can be classified into acute and chronic types. Acute leukemias show a high number of immature cells (blasts), while chronic leukemias have more mature cells but in excessive numbers. Key histological features include:
Increased cellularity in the bone marrow
Presence of abnormal blast cells in acute leukemia
Increased numbers of mature but dysfunctional cells in chronic leukemia
Reed-Sternberg cells in Hodgkin lymphoma
Variable cell sizes and shapes in non-Hodgkin lymphoma
Patterns of growth, such as follicular or diffuse
Clusters or sheets of plasma cells
Presence of
Russell bodies and
Dutcher bodies Bone marrow biopsy showing increased numbers of plasma cells, often more than 10%
Conclusion
Histology is indispensable in diagnosing and understanding hematological malignancies. By analyzing tissue samples at the microscopic level, pathologists can identify the type and extent of malignancy, guiding treatment decisions and improving patient outcomes.